Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of citalopram on negative symptoms of schizophrenia
IRCT20221025056289N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of citalopram in schizophrenia, sponsored by Alborz University of Medical Sciences. Started Apr 2023; status: completed.
02
Drugs
citalopram
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20221025056289N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221025056289N1.